Norman Fishman, M.D.
NPI 1528086659ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Chesterfield, MO
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Chesterfield, Missouri, trained at University of Missouri, Columbia School of Medicine (class of 1974). Their prescriptions cost Medicare Part D more than their services did: $296,958 for 1,193 claims, against $44,951 paid for services in 2024. Novo Nordisk Inc was the largest of 17 companies reporting payments in 2025, $665.57 in all, mostly food and beverage.
Overview
| NPI | 1528086659 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jul 17, 2006 |
| Last updated in NPPES | Oct 21, 2009 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | R6249 | MO |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (MO) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 140 |
|---|---|
| Services billed | 1,194 across 24 procedure codes |
| Paid by Medicare | $44,951 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,193 · 2,770 30-day fills |
|---|---|
| Patients | 148 |
| Total drug cost | $296,958 |
| Generic share | 50% of claims |
Education and affiliations
| Medical school | University of Missouri, Columbia School of Medicine |
|---|---|
| Graduation year | 1974 |
| Medicare specialty | Endocrinology |
Medical group
- Diabetes and Endocrinology Specialists IncChesterfield, MO · 4 clinicians
Hospital affiliation
- St Lukes HospitalChesterfield, MO
Industry payments (Open Payments)
- 2025$665.57 · 34 payments from 17 companies
- 2024$466.32 · 23 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $90.37 | 5 |
| Sequel Med Tech, LLC | $82.74 | 4 |
| Abbvie Inc. | $63.16 | 3 |
| Radius Health, Inc. | $60.27 | 3 |
| Bayer Healthcare Pharmaceuticals Inc. | $50.33 | 3 |
What the 2025 payments were for
- Food and Beverage$665.57 · 34 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Chesterfield
- 1861404675
- 1134670367
- 1306088182
- 1376706861
- 1508916495
- 1538267844
- 1003840349
- 1316350028
- 1255365581
- 1346229838
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Missouri →